X-twitter Linkedin Facebook-f Vimeo

GSK plc

  • Ticker: LON: GSK
GSK

GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical company headquartered in London, England.

About GSK plc

Latest GSK plc Share price

LON: GSK Dividends

Historical Data

Latest GSK plc News

GSK Shingrex

GSK’s Shingrix prefilled syringe approved in Japan

Japan’s health ministry has approved a ready-to-use prefilled syringe presentation of GSK’s Shingrix shingles vaccine, simplifying preparation and administration for...
GSK

GSK gains priority FDA review for Jemperli in rectal cancer

GSK says the US FDA has accepted Jemperli for priority review in previously untreated stage II and III locally advanced...
GSK

GSK filing accepted by EMA for Bexsero booster label update

GSK says the EMA has accepted a submission to update Bexsero’s label to include a single-dose booster for older previously...
GSK plc

GSK reports positive interim AZUR-1 results for Jemperli in rectal cancer

GSK has reported positive interim AZUR-1 results for Jemperli in dMMR/MSI-H locally advanced rectal cancer, with the study meeting its...
GSK

GSK gains US FDA approval for oral cUTI antibiotic Utebzi

GSK has secured US FDA approval for Utebzi, an oral carbapenem antibiotic for certain adult patients with complicated urinary tract...
GSK

GSK receives orphan designations for momelotinib in VEXAS syndrome

GSK has received orphan drug designations for momelotinib in the US and EU for VEXAS syndrome, with phase II/III development...
BIOG

GSK to acquire Biotech Growth Trust portfolio company Nuvalent for $10.6bn

Biotech Growth Trust notes GSK’s agreed $10.6bn cash acquisition of Nuvalent, a BIOG portfolio company focused on targeted cancer therapies....
GSK

Japan expands approval of GSK’s Arexvy to at-risk adults aged 18–49

GSK says Japan has expanded Arexvy eligibility to adults aged 18–49 at increased risk of RSV disease, including immunocompromised patients....
GSK plc

GSK partners with SBP Group to support bepirovirsen launch in China

GSK has entered an exclusive collaboration with SBP Group’s CTTQ unit to accelerate the launch of bepirovirsen, a potential first-in-class...
GSK

GSK wins China approval for Blenrep in previously treated multiple myeloma

The approval covers Blenrep plus bortezomib and dexamethasone for adults with relapsed or refractory multiple myeloma and is supported by...
GSK Plc

GSK adds pulmonary hypertension candidate HS235 through 35Pharma acquisition

GSK has closed its acquisition of 35Pharma, gaining HS235, a potential treatment for pulmonary hypertension that targets the activin receptor...
GSK

GSK expands Exdensur approval in China to CRSwNP

The NMPA has approved Exdensur for adults with chronic rhinosinusitis with nasal polyps, based on phase III data showing improved...
More News

Share this page

Twitter
LinkedIn
Facebook
Email
WhatsApp

Data policy – All information should be used for indicative purposes only. You should independently check data before making any investment decision and or seek professional advice. DirectorsTalk cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used.

Follow us on Social Media:

Home X-twitter Linkedin Facebook Spotify Apple